Clinical trial
Bevacizumab Treatment For Type 1 Retinopathy of Prematurity
NCT04634578 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bevacizumab Treatment For Type 1 Retinopathy of Prematurity
- Lead sponsor
- Jaeb Center for Health Research
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- May 1, 2022
- Completion date
- July 1, 2027
- Enrollment
- 77 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.